Flynn et al. [37] note that RTK3 have higher expression of genes related to inflammatory activity (CCL2 and CYR61 in gene set III), and in our analyses they also seem to have higher expression of the angiogenic and NRAS-regulated matrisomal signatures compared to RTK1 tumours. This evidence concerns the gene CCL2 and neoplasm.